Government Prioritises MedTech As A Strategic Sector, Sets $30 Billion Target By 2030

New Delhi : MedTekon 2025, the flagship event of the Medical Technology Association of India (MTaI), convened policymakers, global dignitaries, investors, and healthcare leaders at Taj Palace. Focused on Investments, Reforms, and Synergies, the event set the agenda for policy acceleration, investment growth, and technological advancements in India’s MedTech sector.
The event was graced by Chief Guest Minister Anupriya Patel, Union Minister of State for Health & Family Welfare and Chemicals & Fertilizers, and Guest of Honour Dr. V. K. Paul, Member, NITI Aayog, who underscored the critical role of medical technology in shaping India’s healthcare future.
While addressing the gathering, Minister Anupriya Patel, Union Minister of State for Health & Family Welfare and Chemicals & Fertilizers said, “It is an honour to inaugurate MedTekon 2025, a key platform uniting industry leaders, policymakers, and healthcare stakeholders to shape the future of India’s MedTech sector. With the industry poised to double its market size to $30 billion by 2030 and expand its global share from 1.65% to 10-12%, India is rapidly emerging as a MedTech powerhouse. Our exports reached $3.8 billion last year, reflecting the sector’s growing manufacturing strength and global competitiveness. As we drive this momentum forward, collaborative efforts in innovation, investment, and policy reforms will be crucial to positioning India as a leader in affordable, high-quality medical technology.”
In his remarks during the session on Catalysing Foreign & Domestic Investments in MedTech, Dr. V. K. Paul, Member, Niti Aayog said, “MedTekon 2025 serves as apt platform to expand India’s global footprint, foster innovation, and strengthen domestic manufacturing. With rising demand for medical devices, India must position itself as a global MedTech leader.
“India’s 4,000+ health-tech startups need greater investment, regulatory support, and structured incubation to scale globally. Additionally, harmonizing regulatory standards with global benchmarks is vital for investor confidence and sector growth. By focusing on innovation, investment, and policy stability, we can cement India’s role as a leader in affordable, high-quality medical technology,” he said.
Mr. Pavan Choudary, Chairman, MTaI, emphasized the need for investment-friendly policies, regulatory coherence, and a robust MedTech infrastructure to support India’s growing healthcare needs and said, “At MTaI, we believe that sharp advocacy stems from thoughtful deliberation, and MedTekon 2025 embodies this commitment.”
In response to a question if technology is responsible for de-humanization and a lot of stress, Mr. Choudary disagreed and highlighted, “The rise of communities like Hikikomori (term used in Japan) for those who prefer technology-driven interactions over human engagement as human interactions can lead to some level of stress and distress. Machines don’t judge and don’t tire and therefore are preferred by the many millions of hikikomories in the world today, whose number is soaring.”